However, our data may have important clinical implications since they suggest that miR-155-5p, together with IL-8, Leptin and RAGE, may be used as biomarker to identify obese individuals with higher risk of developing DM2 and cardiovascular complications. The gene discussed is LEP; the disease is myotonic dystrophy type 2.